Patients managed for acute exacerbation of asthma in acute settings respond to standard management protocol involving systemic and oral steroids. However, relapses are common due to poor adherence to tapering doses of oral steroids. Intramuscular (IM) administration of corticosteroids has been shown to be equipotent to oral steroids with the added advantage of convenient dosing and improved adherence. However, the role of the route of administration of corticosteroids related to relapse of asthma attacks after acute care has not been fully explored. To find and appraise up-to-date evidence in the literature that compares the effectiveness and safety of IM corticosteroids o a short-course oral corticosteroid in the treatment of asthma patients in acute care settings. The principles of evidence-based medicine (EBM) were used. Suitable articles were identified using MEDLINE, Cochrane library, and Google scholar. Titles and summary texts were reviewed. The full article of the relevant article was downloaded for critical appraisal of methodological quality using a measurement tool to assess systematic review 2 (AMSTAR 2). In applying AMSTAR 2 to the selected systematic review article, it was noted that the investigators followed most of the requirements. However, adequate investigation of publication bias and discussion of its likely impact on the review’s result was not done by the researchers. No significant differences in effectiveness and safety were observed between IM corticosteroids and oral corticosteroids among this category of patients. Additional studies are required to compare different IM and oral corticosteroid preparations. Keywords: Acute exacerbation of Asthma, AMSTER 2, Evidence-based medicine, Route of administration of corticosteroids.